Zelira Therapeutics (ZLDAF, $0.49) was one of top quarterly gainers, jumping +6 to $0.49 per share. A.I.dvisor analyzed 872 stocks in the Biotechnology Industry over the last three months, and discovered that of them (4) charted an Uptrend while of them (5) trended down.